News

Researchers led by Maike Sander, scientific director of the Max Delbrück Center, have developed a vascularized organoid model ...
YOKNEAM, Israel, May 19, 2025 /PRNewswire/ -- Cytora, a clinical stage company developing unique stem cell treatments based on human Oral Mucosa Stem Cells (hOMSC), reported today data of an ...
Dr. Simrit Parmar, an associate professor in the College of Medicine at Texas A&M University and founder of the ...
May 16, 2025 — Researchers have developed a method to confidently produce blood cell precursors from stem cells in mice, by activating a set of seven key genes in the laboratory. The team takes ...
Stem cells can produce any other cell type, it is just a matter of telling them in the right way. From a biological perspective, this means activating the proper genetic programme by pressing the ...
The danger becomes clear if you Google "stem cell treatment." You'll get search results from clinics in the U.S. and around the world touting stem cell treatments for conditions ranging from ...
The treatment is now just a step away from being the first ever allogeneic stem cell therapy approved in Europe, and will put the Belgium-based biotech company into the vanguard of cell and gene ...
European regulators has recommended an advanced stem cell therapy which prevents immune reactions following blood cancer stem cell transplants. MolMed’s Zalmoxis is an add-on treatment for ...
Hypoxia impairs the efficacy of stem cell-derived islet cell therapy, making it a potential barrier for treatment of type 1 diabetes. Wang et al. identify EDN3 as a key factor that preserves β ...